WO2007109871A3 - Acridine derivatives with antitumoral activity - Google Patents

Acridine derivatives with antitumoral activity Download PDF

Info

Publication number
WO2007109871A3
WO2007109871A3 PCT/BR2007/000074 BR2007000074W WO2007109871A3 WO 2007109871 A3 WO2007109871 A3 WO 2007109871A3 BR 2007000074 W BR2007000074 W BR 2007000074W WO 2007109871 A3 WO2007109871 A3 WO 2007109871A3
Authority
WO
WIPO (PCT)
Prior art keywords
acridine derivatives
antitumoral activity
formula
antitumoral
activity
Prior art date
Application number
PCT/BR2007/000074
Other languages
French (fr)
Other versions
WO2007109871A2 (en
Inventor
Ivan Da Rocha Pitta
Galdino Suely Lins
De Lima Maria Do Carmo Alves
Original Assignee
Univ Fed De Pernambuco Ufpe
Ivan Da Rocha Pitta
Galdino Suely Lins
De Lima Maria Do Carmo Alves
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Fed De Pernambuco Ufpe, Ivan Da Rocha Pitta, Galdino Suely Lins, De Lima Maria Do Carmo Alves filed Critical Univ Fed De Pernambuco Ufpe
Priority to EP07719242A priority Critical patent/EP2004628A2/en
Publication of WO2007109871A2 publication Critical patent/WO2007109871A2/en
Publication of WO2007109871A3 publication Critical patent/WO2007109871A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses new acridine derivatives according to general formula (I) below, useful as antitumor agents, methods for its preparation as well as pharmaceutical compositions containing the same are also disclosed: (Formula I).
PCT/BR2007/000074 2006-03-24 2007-03-23 Acridine derivatives with antitumoral activity WO2007109871A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07719242A EP2004628A2 (en) 2006-03-24 2007-03-23 Acridine derivatives with antitumoral activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0601827-0A BRPI0601827A (en) 2006-03-24 2006-03-24 molecules with antitumor activity
BRPI0601827-0 2006-03-24

Publications (2)

Publication Number Publication Date
WO2007109871A2 WO2007109871A2 (en) 2007-10-04
WO2007109871A3 true WO2007109871A3 (en) 2009-06-11

Family

ID=38541452

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2007/000074 WO2007109871A2 (en) 2006-03-24 2007-03-23 Acridine derivatives with antitumoral activity

Country Status (3)

Country Link
EP (1) EP2004628A2 (en)
BR (1) BRPI0601827A (en)
WO (1) WO2007109871A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1101273B1 (en) * 2011-03-10 2022-07-19 Universidade Federal De Pernambuco IMIDAZOLIDINE AND THIAZOLDINE MOLECULES WITH ANTI-T.CRUZI ACTIVITIES
WO2013053034A2 (en) * 2011-10-10 2013-04-18 Universidade Federal De Pernambuco - Ufpe Thiazacridines used in anti-cancer therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024058A2 (en) * 2002-09-10 2004-03-25 Conselho Nacional De Desenvolvimento Científico E Tecnológico - Cnpq Molecules with antitumor activity and chemical synthesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024058A2 (en) * 2002-09-10 2004-03-25 Conselho Nacional De Desenvolvimento Científico E Tecnológico - Cnpq Molecules with antitumor activity and chemical synthesis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] XP008120457, Database accession no. 144:22847 *
DATABASE CA [online] XP008120458, Database accession no. 137:78894 *
MOURAO, R.H. ET AL.: "Synthesis and biological acitvity of novel acridinylidene and benzylidene thiazolidinediones", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 40, no. 11, 2005, pages 1129 - 1133 *
SILVA, T.G. ET AL.: "Synthesis and structural elucidation of new benzylidene imidazolidines and acridinylidene thiazolidines", HETEROCYCLIC COMMUNICATIONS, vol. 7, no. 6, 2001, pages 523 - 528 *

Also Published As

Publication number Publication date
WO2007109871A2 (en) 2007-10-04
EP2004628A2 (en) 2008-12-24
BRPI0601827A (en) 2007-11-27

Similar Documents

Publication Publication Date Title
WO2009111653A3 (en) Antiviral therapeutic agents
WO2007140385A3 (en) Thiazole compounds as cannabinoid receptor ligands and uses thereof
ZA200807274B (en) Novel pyridine derivatives
WO2006114520A3 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
WO2008017346A3 (en) Ascorbic acid derivatives, use thereof for the functionalization of matrices
WO2008009831A3 (en) Novel amphiphilic cyclodextrin derivatives
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2007065595A3 (en) Xanthine derivatives, processes for preparing them and their uses
WO2011056511A3 (en) 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
WO2007017728A3 (en) Novel heterocyclic compounds
WO2009013545A3 (en) Chemical compounds
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2010089327A3 (en) Indole derivatives as anticancer agents
MX2009008249A (en) Pharmaceutical composition comprising a campothecin derivative.
WO2008033935A3 (en) Vinorelbine derivatives
WO2008063548A3 (en) 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents
WO2007000655A3 (en) Novel pyrazolopyrimidinone derivatives
WO2008070354A3 (en) 5- and 6- substituted benzimidazole thiophene compounds
WO2008107771A3 (en) 2',3'-di-o-acyl-5-fluoronucleosides
WO2004069145A3 (en) Anticancer compounds, process for their preparation and pharmaceutical compositions containing them
WO2007109871A3 (en) Acridine derivatives with antitumoral activity
WO2006097809A3 (en) Novel tyrosine derivatives
WO2007070568A3 (en) Demethylpenclomedine analogs and their use as anticancer agents
HK1131156A1 (en) Novel morphine derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07719242

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007719242

Country of ref document: EP